succimer has been researched along with stibocaptate* in 42 studies
42 other study(ies) available for succimer and stibocaptate
Article | Year |
---|---|
Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
The currently available anti-leishmanial antimonial drugs, together with other antimony compounds were individually tested, in combination with difluoromethylornithine (DFMO), against experimental murine trypanosomiasis with central nervous system involvement. Satisfactory cure rates could be achieved using a combination treatment of DFMO with most of these anti-leishmanial drugs, but in general, only when they were administered at least twice daily. Of the compounds tested, the most effective was antimony dimercaptosuccinate (Astiban). Topics: Animals; Antimony; Antimony Sodium Gluconate; Drug Synergism; Drug Therapy, Combination; Eflornithine; Female; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Succimer; Tartrates; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Schistosoma haematobium: the effect of Astiban on the cell composition and ultrastructure of the vitelline gland and the ultrastructure of the tegument and gastrodermis.
Treatment of Schistosoma haematobium (Nigerian strain) in hamsters with a single dose of 40 mg/kg of Astiban caused a reduction in the number of S1, S2, and S3 vitelline cells and an increase in S4 cells. Following seven daily doses of the drug, a marked reduction in S1 cells and a complete loss of S2 and S3 cells occurred such that 95% of the cells were S4 cells, all of which were structurally abnormal. Coagulation and disintegration of the protein granules of the vitelline droplets occurred with increase in lipid droplets, swelling of the nuclear membrane and an increase in cytosegresomes. Blebbing of the tegument in both sexes occurred following a single treatment and vacuolation of the basal infolds and alterations to the mitochondria also resulted, but severe erosion of the tegument was rare even following repeated drug treatment. Damage to the gastrodermis was severe with the development of autophagic vacuoles containing whorls of myelin and sequestered portions of damaged tissue. The degree of damage increased with the number of drug treatments. Topics: Animals; Cricetinae; Dose-Response Relationship, Drug; Female; Male; Microscopy, Electron; Organometallic Compounds; Schistosoma haematobium; Schistosomiasis haematobia; Schistosomicides; Succimer; Sulfhydryl Compounds | 1990 |
Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Injections, Intradermal; Leishmaniasis; Male; Organometallic Compounds; Succimer; Sulfhydryl Compounds | 1988 |
On the treatment of cutaneous leishmaniasis in Egypt.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Organometallic Compounds; Succimer; Sulfhydryl Compounds | 1986 |
Microencapsulation of astiban acid for the treatment of Schistosomiasis mansoni.
Schistosomiasis is among the top five diseases in the world in terms of morbidity, affecting perhaps 200 million people in tropical and subtropical countries. Antischistosomal drugs are toxic and rapidly metabolized. Hence, they must be given in a number of spaced doses. In spite of this there are severe side effects leading to poor patient compliance. This is an ideal situation for the application of sustained drug release to avoid the toxic peak concentration of drug. This study was carried out using Astiban acid, an antimonial drug that is effective against S. mansoni. Unfortunately, the drug is sufficiently soluble that 50 mg will dissolve in 100 mL water in less than a minute. To permit sustained release of intramuscularly injected drug, microcapsules of astiban acid in poly(d,l-lactic acid) were formed by coacervation. Release studies show that an appreciable fraction of the drug is available at the surface for rapid solution. After this surface drug dissolves, the remaining drug is released slowly with half-times of many hours. After the initial burst, the release of drug follows Higuchi's equation up to approximately 80% release, with exponentially decreasing release rates thereafter. Topics: Antimony; Capsules; Humans; Lactates; Lactic Acid; Organometallic Compounds; Polyesters; Polymers; Schistosoma mansoni; Schistosomiasis; Schistosomicides; Succimer; Sulfhydryl Compounds | 1984 |
Schistosoma mansoni: an in vivo study of drug-induced autophagy in the gastrodermis.
The effects of Astiban, Lucanthone, Hycanthone and Niridazole on autophagic activities in the gastrodermis of Schistosoma mansoni were determined in vivo, using different dosage levels and dosage times. With Astiban, high levels of autophagy were observed in the gastrodermis 2 hours after an injection of the drug into the mouse, and this response had declined by 20 hours, marking a recovery by the parasite from the drug. Hycanthone and Lucanthone produced an autophagic response several days after the onset of treatment, and no recovery was observed in the morphology of the gastrodermis after the drug was discontinued. The effects of Niridazole on the gastrodermis were to produce the most dramatic ultrastructural changes after high doses and over several days of treatment. With all the drugs examined, gastrodermal autophagy was characterized by the formation of vacuoles containing cell components, lipid droplets and sometimes hydrolytic enzyme reaction product. The autophagic vacuoles appeared to be formed by the sequestration of cytoplasmic material by the basal membrane infoldings, and the transfer of enzymes into the vacuole from within the limiting membrane. The residues from intracellular digestion appeared to be emptied into the caecal lumen. Topics: Animals; Antimony; Hycanthone; Lucanthone; Mice; Niridazole; Organometallic Compounds; Schistosoma mansoni; Schistosomiasis; Schistosomicides; Succimer | 1984 |
Treatment of cutaneous leishmaniasis in Saudi Arabia.
Topics: Antimony; Antiprotozoal Agents; Drug Evaluation; Female; Humans; Leishmaniasis; Male; Organometallic Compounds; Rifampin; Succimer | 1983 |
A case of oriental sore diagnosed as pseudolymphoma cutis.
Topics: Antimony; Female; Humans; Leishmania; Leishmaniasis; Middle Aged; Organometallic Compounds; Succimer | 1983 |
Schistosoma mansoni: Astiban-induced damage to tegument and the male reproductive system.
Topics: Animals; Antimony; Genitalia, Male; Male; Mice; Mice, Inbred Strains; Organometallic Compounds; Schistosoma mansoni; Schistosomicides; Succimer; Sulfhydryl Compounds; Testis | 1981 |
Antitrypanosomal activity of trivalent antimonials in vitro and its significance.
The SbIII preparations available for clinical use were compared in vitro for their concentration/time/effect curves on Trypanosoma venezuelense (T. evansi), measuring decrease of motility and of parasite numbers. With these two criteria leading to similar relative results, the drugs are classified into a rapidly acting group, led by sodium emetic (AST), followed by its dimethylcysteine chelate (NAP) and Anthiomaline, and a less and more slowly acting one: Triostam, Astiban and Stibophen. The relative activity of these drugs in vitro is parallel to that encountered against Schistosoma mansoni, attributed to a similar pattern of intracellular absorption. In vivo effectiveness may depend on bioavailability of Sb in the host and the direct action on the parasite, reflected by its in vitro activity. The interplay of these two factors leads to a different in vitro/in vivo activity relationship of the antimonials even in the same host (mouse) and to its variation in other host species. Topics: Antimony; Antimony Sodium Gluconate; Benzenesulfonates; Cysteine; In Vitro Techniques; Organometallic Compounds; Succimer; Succinates; Tartrates; Trypanocidal Agents; Trypanosoma | 1980 |
[Schistosomiasis clinically active for 25 years].
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Succimer; Sulfhydryl Compounds; Time Factors | 1980 |
Chemotherapy of Trypanosoma venezuelense (T. evansi), I. Activity of trivalent antimonials in mice by long and short term tests.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Benzenesulfonates; Drug Administration Schedule; Mice; Organometallic Compounds; Succimer; Succinates; Time Factors; Trypanosomiasis | 1980 |
Fatal stibocaptate toxicity.
Topics: Aged; Antimony; Child, Preschool; Female; Humans; Organometallic Compounds; Schistosomiasis; Succimer; Sulfhydryl Compounds | 1980 |
Influence of astiban on liver, spleen kidney and bladdet beta.glucuronidase of normal and Schistosoma mansoni infected mice.
Topics: Animals; Antimony; Glucuronidase; Kidney; Liver; Mice; Organometallic Compounds; Schistosoma mansoni; Schistosomiasis; Spleen; Succimer; Sulfhydryl Compounds; Time Factors; Urinary Bladder | 1979 |
Studies with Brugia pahangi. 18. Anthelmintic effects of stibocaptate.
Stibocaptate (Asiban, Hoffman--La Roche) killed third stage larvae of Brugia pahangi in vitro at 50 p.p.m. but had no effect on microfilariae at 1 X 10(4) p.p.m No larvae developed in infected mosquitoes fed 1% stibocaptate in 10% sucrose. It was neither micro-nor macrofilaricidal in either jirds or cats but did affect embryogenesis. Topics: Animals; Antimony; Brugia; Cats; Culicidae; Dose-Response Relationship, Drug; Female; Filarioidea; Male; Organometallic Compounds; Succimer; Succinates | 1978 |
The effects of some drugs--pentamidine, stibocaptate, Hoechst 33258, F 151, compound 'E' and Nifurtimox--on Onchocerca volvulus in chimpanzees.
Several drugs were investigated for action against Onchocerca volvulus in chimpanzees. Pentamidine at 4 mg/kg daily for 16 days had no filaricidal action; nor did stibocaptate at 10 mg/kg monthly for 8 months. Hoechst 33258, a substituted bis-benzamidazole, showed micro- and macrofilaricidal activity; F151 (an arsenical compound) showed a purely macrofilaricidal action; and Compound E (a reaction product of Hoechst 33258 and F151) was micro- and macrofilaricidal. The toxicity of the three last-mentioned compounds was high, and further trials were not made. Nifurtimox, at doses of up to 40 mg/kg for 10 days, was shown not be microfilaricidal, but there was a suggestion that this drug may have some macrofilaricidal action. Topics: Animals; Anthelmintics; Antimony; Arsenicals; Bisbenzimidazole; Female; Male; Nifurtimox; Onchocerca; Onchocerciasis; Organometallic Compounds; Pan troglodytes; Pentamidine; Succimer; Succinates | 1977 |
THERAPEUTIC RESULTS OBTAINED WITH INTRAMUSCULAR ASTIBAN IN URINARY SCHISTOSOMIASIS.
Topics: Africa; Africa, Western; Antimony; Child; Drug Therapy; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1965 |
ANTIBACTERIAL ACTION OF ASTIBAN.
Topics: Animals; Anti-Bacterial Agents; Antimony; Intestines; Mice; Organometallic Compounds; Pharmacology; Research; Salmonella; Succimer | 1965 |
[TREATMENT OF MANSON'S SCHISTOSOMIASIS WITH DIMERCAPTO-SUCCINATE OF ANTIMONY AND SODIUM (ASTIBAN)].
Topics: Antimony; Humans; Ions; Organometallic Compounds; Schistosomiasis; Sodium; Sodium, Dietary; Succimer; Succinates; Succinic Acid | 1964 |
"ASTIBAN" THERAPY IN BILHARZIASIS; ITS URINARY EXCRETION ESTIMATED BY A NEW POLAROGRAPHIC TECHNIQUE.
Topics: Antimony; Body Fluids; Organometallic Compounds; Polarography; Schistosomiasis; Succimer; Toxicology; Urine | 1964 |
BIOLOGICAL DISPOSITION OF SOME ANTIMONYL ANTIBILHARZIAL DRUGS: SODIUM ANTIMONY-2,3-MESO-DIMERCAPTO-SUCCINATE (ASTIBAN) IN ANIMALS INFECTED WITH SCHISTOSOMA MANSONI.
Topics: Animals; Antimony; Autoradiography; Cricetinae; Intestines; Liver; Mice; Organometallic Compounds; Pathology; Radioisotopes; Research; Schistosoma; Schistosoma mansoni; Sodium; Succimer; Succinates; Succinic Acid | 1964 |
CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: PROPHYLACTIC, PROTECTIVE AND THERAPEUTIC ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID IN MICE AND HAMSTERS.
Topics: Animals; Antimony; Cricetinae; Dosage Forms; Mice; Organometallic Compounds; Pharmacology; Research; Schistosomiasis; Schistosomiasis mansoni; Sodium; Succimer; Succinates | 1964 |
ASTIBAN IN SCHISTOSOMIASIS MANSONI: A CONTROLLED THERAPEUTIC TRIAL IN A NONENDEMIC AREA.
Topics: Adolescent; Antimony; Biomedical Research; Drug Therapy; Organometallic Compounds; Schistosomiasis; Schistosomiasis mansoni; Succimer; Toxicology | 1964 |
TREATMENT OF URINARY SCHISTOSOMIASIS IN GHANAIANS WITH TWSB (ASTIBAN).
Topics: Adolescent; Africa; Africa, Western; Antimony; Child; Drug Therapy; Ghana; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Toxicology | 1964 |
CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: INFLUENCE OF DIMERCAPTOSUCCINIC ACID ON THE TOXICITY AND ANTISCHISTOSOMAL ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND OTHER ANTIMONY COMPOUNDS IN MICE.
Topics: Antimony; Antiprotozoal Agents; Emetine; Mice; Organometallic Compounds; Pharmacology; Research; Schistosomiasis; Schistosomiasis mansoni; Sodium; Succimer; Succinates | 1964 |
CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: DISTRIBUTION OF ANTIMONY-124 IN MICE AND HAMSTERS AFTER A SINGLE DOSE OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID.
Topics: Animals; Antimony; Blood; Chemical Phenomena; Chemistry; Cricetinae; Intestines; Kidney; Liver; Mice; Organometallic Compounds; Pharmacology; Radioisotopes; Research; Schistosomiasis; Schistosomiasis mansoni; Sodium; Succimer; Succinates | 1964 |
Observations on the treatment of schistosomiasis mansoni with antimony dimercaptosuccinate (TWSb).
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis mansoni; Succimer | 1963 |
The suppressive activity of sodium antimony dimercaptosuccinate (TWSB) in experimental infections with Schistosoma mansoni.
Topics: Animals; Antimony; Antiparasitic Agents; Humans; Organometallic Compounds; Schistosoma mansoni; Schistosomiasis; Sodium; Succimer | 1963 |
ON THE SHORT-TERM ANTIBILHARZIAL THERAPY WITH SODIUM ANTIMONY DIMERCAPTOSUCCINATE.
Topics: Acids, Noncarboxylic; Antimony; Humans; Organometallic Compounds; Schistosomiasis; Sodium; Sodium, Dietary; Succimer; Succinates; Toxicology | 1963 |
Ambulant treatment of urinary schistosomiasis with Astiban (TWSb/6).
Topics: Antimony; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1962 |
Electrocardiographic effects of antimony dimercapto-succinate ('astiban').
Topics: Antimony; Electrocardiography; Organometallic Compounds; Schistosomiasis; Succimer; Succinates; Succinic Acid | 1962 |
Astiban in treatment of urinary bilharziasis in Iraq.
Topics: Antimony; Humans; Iraq; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1962 |
Fatality after antimony dimercapto-succinate ("Astiban").
Topics: Antimony; Hepatitis; Hepatitis A; Organometallic Compounds; Schistosomiasis; Shock, Septic; Succimer; Succinates; Succinic Acid | 1962 |
A comparison of Astiban (Twsb) and Miracil D in the therapy of school children suffering from urinary bilharziasis in Iraq.
Topics: Antimony; Iraq; Lucanthone; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Urinary Tract Infections | 1962 |
Cardiotoxic effects of antimony dimercaptosuccinate in schistosomiasis with special reference to coexistent hepatic dysfunction.
Topics: Antimony; Heart; Humans; Liver Diseases; Organometallic Compounds; Schistosomiasis; Succimer; Succinates; Sulfhydryl Compounds | 1962 |
Treatment of Schistosoma haematobium infection with sodium antimony dimercaptosuccinate (TWSb).
Topics: Animals; Antimony; Humans; Organometallic Compounds; Schistosoma haematobium; Schistosomiasis; Schistosomiasis haematobia; Sodium; Sodium, Dietary; Succimer | 1962 |
Suppressive management of schistosomiasis with antimony dimercaptosuccinate.
Topics: Antimony; Organometallic Compounds; Schistosomiasis; Succimer | 1961 |
[Treatment of schistosomiasis mansoni by antimony dimercaptosuccinate (TWSb). Comparison with tartar emetic].
Topics: Antimony; Antimony Potassium Tartrate; Organometallic Compounds; Schistosomiasis; Schistosomiasis mansoni; Succimer | 1961 |
Antimony dimercaptosuccinate (TWSb) in the treatment of urinary bilharziasis in Somalia.
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Somalia; Succimer; Urinary Tract Infections | 1960 |
Sodium antimony dimercaptosuccinate (Sb-58) in treatment of schistosomiasis japonica.
Topics: Acids, Noncarboxylic; Antimony; Organometallic Compounds; Schistosomiasis; Schistosomiasis japonica; Sodium; Sodium, Dietary; Succimer; Succinates | 1960 |
Treatment of urinary bilharziasis with antimony dimercaptosuccinate (TWSb).
Topics: Antimony; Humans; Organometallic Compounds; Schistosomiasis; Schistosomiasis haematobia; Succimer; Succinates; Urologic Diseases | 1958 |
Treatment of bilharziasis with antimony dimercaptosuccinate.
Topics: Antimony; Organometallic Compounds; Schistosomiasis; Succimer | 1958 |